#Precision Medicine
9 articles with this tag
Treeline Biosciences Raises $200M, Initiates Clinical Trials
The company also initiated Phase 1 trials for three oncology programs, including a pan-KRAS inhibitor.
Dia Beta Labs Raises €1.4M for Diabetes Cell Therapies
Dia Beta Labs secured €1.4 million in funding from undisclosed investors. This investment will advance its development of next-generation therapies for obesity and Type 2 diabetes. The company's technology focuses on protecting and repairing insulin-producing beta-cells.
Plexision Secures $365K for AI Transplant Prediction
PODCAST: I've Learned to Avoid Saying 'Never' Because Technology Proceeds in Ways that you Often Don’t Expect
AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition
Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
Aignostics Raises $34 Million Series B to Accelerate Precision Medicine with AI
<p>Aignostics has raised $34 million in a Series B round to expand product offerings, grow its U.S. presence, and co-develop foundation models for pathology with Mayo Clinic.</p> <p>The funding, led by ATHOS with participation from Mayo Clinic and other investors, brings Aignostics' total raised to over $55 million.</p> <p>The company plans to launch scalable AI solutions for tumor profiling and biomarker analysis, leveraging its recent successes, including the release of its first foundation model, RudolfV.</p>
The Israeli AI Healthcare Startup Landscape of 2018
